The gastric cancer market is expected to reach $10.7 billion by

Portland, Oregon, April 14, 2023 (GLOBE NEWSWIRE) — According to a report published by Allied Market Research, global stomach cancer market generates $2.1 billion in 2021 and is expected to reach $10.7 billion by 2031, witnessing a CAGR of 17.9% from 2022 to 2031 The report offers detailed analysis of changing market trends, top segments, key investment pockets, value chains, regional landscapes and competitive scenarios. The report is a useful source of information for leading market players, new entrants, investors, and stakeholders in developing strategies for the future and taking steps to strengthen their position in the market.

Request a sample PDF brochure-

Report coverage and details:

Report coverage Details
Forecast period 2021–2031
Base year 2021
Market size in 2021 2.1 billion dollars
Market Size in 2031 $10.7 billion
CAGR 17.9%
Number of pages in the report 350
Covered segments Disease type, treatment type, drug class outlook, route of administration, distribution channel and region
Drivers The increasing incidence of gastric cancer requires effective treatment
The rise of obesity and excessive consumption of highly processed foods, sugary drinks, tobacco, genetic modification of genes, families with cancer and alcohol
Opportunities Increase in the number of stomach cancer cases

The high cost of stomach cancer treatment

Covid-19 scenario:

  • The COVID-19 pandemic has had a negative impact on healthcare systems around the world, including those dealing with cancer diagnosis and treatment. In addition, the pandemic has caused delays in diagnosis and treatment, changes in treatment regimens, and shutdowns in cancer research.
  • Delays in the diagnosis and treatment of stomach cancer were the main impacts of the COVID-19 pandemic. To reduce the risk of transmission of COVID-19, many hospitals and clinics have been forced to postpone or cancel non-urgent procedures and appointments. This has led to delays in cancer diagnosis and treatment, making it difficult for patients to stay healthy.
  • The pandemic has also hampered efforts to find new treatments for stomach cancer through clinical trials. thanks to government initiatives that have imposed strict regulation and blocking around the world. Several clinical trials have been delayed or halted, delaying the development of new disease-modifying therapies.
  • Despite these challenges, the global gastric cancer market has rebounded since the pandemic.

Provide full report (350 page PDF with information, charts, tables and figures)

The report offers detailed segmentation of the global gastric cancer market based on disease type, treatment type, drug class outlook, route of administration, distribution channel, and region. The report provides analysis of each segment and sub-segment with the help of tables and figures. This analysis helps the market players, investors and new entrants in determining the sub-segments to use to achieve growth in the coming years.

By disease type, the adenocarcinoma, solutions segment contributed nearly two-fifths of the global gastric cancer market revenue and is expected to rule by 2031. The same segment will also show the fastest CAGR of 18.9% during the entire forecast period. Lymphoma, gastrointestinal stromal tumor, carcinoid tumor, and other segments are also discussed in the report.

By treatment type, the chemotherapy segment garnered almost half of the global gastric cancer market revenue and is expected to dominate by 2031. However, the targeted therapy segment will post the fastest CAGR of 19.2% throughout the forecast period. Also, the immunotherapy and radiotherapy and surgery segments are studied in the report.

According to the drug class outlook, the PD-1/PD-L1 inhibitors segment will show the fastest CAGR of 18.7% throughout the forecast period. HER2 antagonists, VEGFR2 antagonists and other segments are also analyzed in the report.

By distribution channel, the specialty pharmacy and retail pharmacy segment contributes nearly three-fifths of the global gastric cancer market revenue and is expected to maintain its dominant position until 2031. The same segment will also post the fastest CAGR of 18.5 % throughout the forecast period. Hospital pharmacies and other segments are also evaluated through the report.

For Purchase Inquiry-

By region, Asia Pacific held the major share in 2021, garnering more than half of the global gastric cancer market revenue and is expected to rule in terms of revenue during the forecast period. Simultaneously, the Europe region will exhibit the fastest CAGR of 18.8% throughout the forecast period. Other provinces explored in the report include North America and LAMEA.

The key market players analyzed in the global gastric cancer market report include samsung bioepis, Celltrion Healthcare Co., Ltd., Eli Lilly & Company, Merck & Co., Inc., Bristol Myers Squibb Company, Mylan NV, Novartis AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd. and F. Hoffmann La Roche Ltd. These market players have adopted several strategies including partnership, expansion, collaboration, joint ventures and others to highlight their might in the industry. The report is helpful in formulating the business performance and development of the leading players.

Healthcare Trend Reports –

mHealth Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Biomaterials Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

Flow Cytometry Market – Global Opportunity Analysis and Industry Forecast, 2021-2030.

Healthcare IT Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

MRI Systems Market – Global Opportunity Analysis and Industry Forecast, 2021-2030

AVENUE – Subscription-based library (premium on-demand, subscription-based pricing model):

AMR introduces its online premium subscription library Avenue, designed specifically to offer a cost-effective one-stop solution for enterprises, investors and universities. With Avenue, subscribers can benefit from an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Additionally, users can access quantitative and qualitative data in PDF and Excel formats online, along with analyst support, customization, and updated report versions.

Access your report library anytime from any device, anywhere. For more details follow the link:

About Allied Market Research:

Allied Market Research (AMR) is the market research and business consulting arm of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of Market Research Reports and Business Intelligence Solutions. AMR has a single-minded focus on providing business insights and consulting to help its clients make strategic business decisions and achieve sustainable growth in their respective market areas. AMR offers its services in 11 industry verticals including Life SciencesConsumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverage, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense and BFSI.

We are in professional corporate relationship with various companies and this helps us to extract market data which helps us to generate accurate data tables from surveys and confirms extreme accuracy in our market forecasts. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high data quality and help clients in every possible way to achieve success. All the data presented in the reports published by us are derived through primary interviews with senior executives from leading companies in the respective domain. Our secondary data delivery methodology involves in-depth online and offline research and discussions with experienced industry professionals and analysts.


David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
[email protected]

Leave a Comment

Your email address will not be published. Required fields are marked *